Founded
22 Dec 2009
Address
5AM Venture Management LLC
Waltham Woods Corporate Center
Suite 140 890 Winter Street
Waltham, MA 02451
United States
Phone
Website
Industry
VCID: 36292
Profile
Corporate information
Official name
5AM Venture Management Limited Liability Company
Also known as
5AM Ventures
Registration country
Official name
5AM Venture Management Limited Liability Company
Also known as
5AM Ventures
Registration country
Investment activity status
Active investor
Funds managed
| Fund | Type | Vintage |
|---|---|---|
| 5AM Ventures V LP | Venture | 2016 |
| 5AM Co-investors IV LP | Venture | 2013 |
| 5AM Co-investors III LP | Venture | 2010 |
| 5AM Ventures III LP | Venture | 2009 |
| 5AM Ventures II LP | Venture | 2006 |
| 5AM Ventures LP | Venture | 2002 |
| 5AM Ventures IV LP | Venture |
Team
Current employees
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
|
Andrew Schwab |
Funding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Versant Ventures Management LLC | Venture capital firm focused on making investments in the healthcare and biotechnology industries. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Versant Ventures Management LLC Venture capital firm focused on making investments in the healthcare and biotechnology industries. |
+1 (949) 729-4500 |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Cleave Biosciences Inc Drug development company focused on novel targets in cellular protein homeostasis pathways |
United States | 11 Nov 2011 | Series A Active |
|
|
|
DVS Sciences Inc An analytical instrument and reagents company founded in Toronto |
United States | 14 Jul 2011 | Series A |
|
|
|
Semprus BioSciences Develops implantable and permanently-antimicrobial surface technology that is incorporated into medical devices |
United States | 1 Dec 2008 1 Dec 2010 |
Series B |
|
|
|
Ceterix Orthopedics Inc Develops technologies to address unmet clinical needs in arthroscopic surgery |
United States | 1 Oct 2010 | Series A |
|
|
|
Igenica Inc A monoclonal-antibody discovery and development company |
United States | 10 Jun 2010 | Series B |
|
|
|
Incline Therapeutics Inc Patient controlled analgesia |
United States | 1 Jun 2010 | Series A |
|
|
Achaogen Inc Develops solutions to the problem of drug resistance |
United States | 1 Apr 2010 | Series C Active |
|
|
|
Pearl Therapeutics Inc Developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases |
United States | 1 Feb 2010 1 Jul 2008 |
N/A |
|
|
|
Flexion Therapeutics Inc Discovers and develops innovative therapeutics for musculoskeletal disorders |
United States | 19 Oct 2009 | Series A |
|
|
|
Rennovia Inc Developing processes to make high-value known chemicals derived from renewable bio sources that have both financial and green advantages |
United States | 18 Sep 2009 | Series A |
|
|
Ambrx Inc A clinical stage biopharmaceutical company with a broad biologics platform that allows it to create best-in-class protein therapeutics. |
United States | 1 Apr 2009 | Series D Active |
|
|
|
Pulmatrix Inc Discovering a new class of host-targeted therapies that pathogen independently treat |
United States | 1 Mar 2009 | Series A |
|
|
|
Synosia Therapeutics Develops innovative treatments for disorders of the central nervous system |
United States | 1 Jan 2009 5 Jan 2007 |
Series B |
|
|
|
PhaseRx Inc Develops novel approaches to the delivery of siRNA and other macromolecules |
United States | 28 Feb 2008 | Series A |
|
|
|
Anaphore Inc Developing a novel class of protein therapeutics, Atrimers, to address significant unmet medical needs in immune-mediated diseases and oncology. |
United States | 1 Jan 2008 | N/A USD 3,300,000 (USD 3,300,000) deal size. |
|
|
|
Relypsa Inc Leads the discovery and development of new non-absorbed polymeric drugs |
United States | 29 Oct 2007 | Series A |
|
|
|
Wildcat Discovery Technologies Inc Discovery and assay methods to accelerate the development of advanced materials for energy storage applications including Lithium ion batteries |
United States | 1 Nov 2006 | Series A |